Journal of Andrology Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Published-Ahead-of-Print January 9, 2008, DOI:10.2164/jandrol.107.004242
Journal of Andrology, Vol. 29, No. 3, May/June 2008
Copyright © American Society of Andrology
DOI: 10.2164/jandrol.107.004242

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
29/3/345    most recent
Author Manuscript (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hu, G.-X.
Right arrow Articles by Ge, R.-S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hu, G.-X.
Right arrow Articles by Ge, R.-S.

Inhibition of 11β-Hydroxysteroid Dehydrogenase Enzymatic Activities by Glycyrrhetinic Acid In Vivo Supports Direct Glucocorticoid-Mediated Suppression of Steroidogenesis in Leydig Cells

GUO-XIN HU*, HAN LIN{dagger},{ddagger}, CHANTAL M. SOTTAS{ddagger}, DAVID J. MORRIS§, MATTHEW P. HARDY|| AND REN-SHAN GE*,{ddagger}

From the * Institute of Molecular Toxicology and Pharmacology, School of Pharmacy, and the {dagger} Institute of Neuroendocrinology and 2nd Affiliated Hospital, Wenzhou Medical College, Wenzhou, Zhejiang, People's Republic of China; the {ddagger} Population Council and The Rockefeller University, New York, New York; and the § Department of Pathology and Laboratory Medicine, The Miriam Hospital, Brown University School of Medicine, Providence, Rhode Island.

Correspondence to: Dr Ren-Shan Ge, The Population Council, 1230 York Avenue, New York, NY 10021 (e-mail: rge{at}popcbr.rockefeller.edu).


Previous studies have suggested that glucocorticoid (GC) can directly affect testicular testosterone (T) biosynthesis by Leydig cells through a receptor-mediated mechanism. Interconversion of corticosterone (CORT), the active form in rodents, and 11-dehydroCORT, the biologically inert 11-keto form, is catalyzed by 11βHSD1. This enzyme thus controls the intracellular concentration of active GC. We have postulated that elevated CORT levels resulting from stress exceed the Leydig cell's capacity for metabolic inactivation of CORT, resulting in suppressed T production. The present study tested whether inhibition of 11βHSD1 in vivo, by the administration of glycyrrhetinic acid (GA), increases intracellular active GC concentration and thereby affects serum T concentration and Leydig cell T production. Adult Sprague-Dawley rats were treated with vehicle (corn oil), CORT, GA, or GA + CORT. Serum luteinizing hormone (LH), CORT, and T levels were measured, as were the steroidogenic capacities of purified Leydig cells. Twofold elevations of CORT were achieved by the administration of either CORT or GA alone, but in both cases there was no effect on serum T levels. However, when CORT and GA were administered in combination, serum CORT levels increased 3.5-fold (to 420 ± 34 ng/mL) and serum T levels were reduced significantly (to 0.72 ± 0.07 ng/mL; control, 2.12 ± 0.23 ng/mL). Serum levels of LH were not affected by CORT, GA, or GA + CORT. Consistent with the reduced serum T levels following GA + CORT, steroidogenic enzyme expression and capacities were significantly reduced compared to control. These data support a role for 11βHSD1 in modulating intracellular CORT concentrations and, in turn, for a direct effect of GC on Leydig cells in response to stress.

     Key words: CORT, testosterone







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2008 by The American Society of Andrology.